Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment
    • AstraZeneca opens new...

    AstraZeneca opens new development operations centre in Bengaluru

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-06-01T15:05:00+05:30  |  Updated On 1 Jun 2019 9:35 AM GMT
    AstraZeneca opens new development operations centre in Bengaluru

    Bengaluru: Drug firm AstraZeneca Thursday said it has opened a new development operations centre in Bengaluru to support the expansion of its clinical research footprint in India.


    "The development operations centre will employ over 30 clinical research experts that handle over 20 studies in 150 sites across India," AstraZeneca said in a statement.









    Read Also: Patent Infringement: AstraZeneca moves court against Aurobindo Pharma on the generic version of Daliresp



    This expansion will focus on managing studies in India to not only support the global clinical drug development, but also the local business with clinical data and evidence, it added.

    "Because of the excellent skills of Indian clinical research experts and the improvement of regulations and approval timelines, we are pleased to expand our operations and continue to lead clinical research in India," AstraZeneca Development Operations (Site Management and Monitoring), Asia, Middle East & Africa (AMEA) Senior Regional Director Melissa Grady said.

    The unit will support the development of AstraZeneca's medicines, hosting clinical trial experts focused on the company's core therapeutic areas - oncology, cardiovascular, renal and metabolism, as well as respiratory, the statement said.

    Read Also: AstraZeneca shows cardiovascular safety for roxadustat in global Phase III trials








    Headquartered at Cambridge UK, AstraZeneca plc is a British-Swedish multinational pharmaceutical and biopharmaceutical company.

    AMEA AstraZeneca AztraZeneca Pharma India Managing Director Bengaluru Cardiovascular India Innovative Medicines Investment Melissa Grady Metabolism oncology renal respiratory Richard Homer Swedish drugmaker AstraZeneca 
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      X